Application of artificial intelligence in microbiome study promotes precision medicine for gastric cancer
Zhi-Ming Li, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Zhi-Ming Li, Xuan Zhuang, Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian Province, China
Xuan Zhuang, Department of Clinical Medicine, Fujian Medical University, Fuzhou 350122, Fujian Province, China
Author contributions: Li ZM conceptualized the paper; Li ZM and Zhuang X wrote the paper; all authors read and approved the final manuscript.
Supported by Health Commission of Hubei Province Scientific Research Project, No. WJ2021Q023.
Conflict-of-interest statement: The authors declare that they have no competing interests to disclose.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhi-Ming Li, PhD, Academic Fellow, Tongji Medical College, Huazhong University of Science and Technology, Baofeng Street, Qiaokou District, Wuhan 430030, Hubei Province, China. firstname.lastname@example.org
Received: March 16, 2021
Peer-review started: March 16, 2021
First decision: April 15, 2021
Revised: April 22, 2021
Accepted: July 9, 2021
Article in press: July 9, 2021
Published online: August 28, 2021